NICOTINE TRANSDERMAL SYSTEM STEP 3

Generic: NICOTINE, NICOTINE TRANSDERMAL SYSTEM PATCH

Topco Associates LLCManufacturer
TRANSDERMALRoute
NICOTINEActive Substance
1991-11-27Original Approval

NICOTINE TRANSDERMAL SYSTEM STEP 3 is FDA application NDA020076, sponsored by DR REDDYS LABS SA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
DRUG INEFFECTIVE
1,784 reports
2
NAUSEA
1,111 reports
3
PRODUCT ADHESION ISSUE
986 reports
4
HEADACHE
785 reports
5
OVERDOSE
784 reports
6
NICOTINE DEPENDENCE
759 reports
7
FOETAL EXPOSURE DURING PREGNANCY
758 reports
8
TREATMENT NONCOMPLIANCE
687 reports
9
DYSPNOEA
673 reports
10
PAIN
636 reports